Cross-sectional echocardiography was performed in 134 patients with hypertrophic cardiomyopathy and 75 with secondary left ventricular hypertrophy (57 hypertensives and 18 athletes) to determine the diagnostic sensitivity and specificity and predictive value of the pattern of left ventricular hypertrophy. Myocardial wall thickness was assessed in the anterior and posterior septum, free wall and posterior wall in both the upper and lower left ventricle. All patients had at least one region exceeding 2 SD from normal (greater than 1.4 cm). Asymmetrical septal hypertrophy) septum to posterior wall ratio greater than or equal to 1.5:1 in the upper or lower left ventricle) was found in 75 patients with hypertrophic cardiomyopathy (56%), 11 hypertensives (18%) and 4 (22%) athletes. This pattern was more common in patients with primary compared to secondary left ventricular hypertrophy (P less than 0.01). Distal ventricular hypertrophy was only seen in patients with hypertrophic cardiomyopathy (10%). Symmetrical left ventricular hypertrophy was demonstrated in 45 patients with hypertrophic cardiomyopathy (34%), 50 hypertensives (82%) and 14 athletes (78%). This pattern was significantly more common in patients with secondary left ventricular hypertrophy (P less than 0.01). Amongst those with symmetrical hypertrophy, patients with hypertrophic cardiomyopathy had more severe hypertrophy while the athletes had larger left ventricular cavity size. Asymmetrical septal hypertrophy was the most sensitive (56%) and distal ventricular (100%) the most specific pattern for the diagnosis of hypertrophic cardiomyopathy with a predictive value of 83 and 100% respectively. Symmetrical left ventricular hypertrophy was 81% sensitive and 66% specific with a predictive value of 58% for the diagnosis of secondary hypertrophy.(ABSTRACT TRUNCATED AT 250 WORDS)

Download full-text PDF

Source
http://dx.doi.org/10.1093/oxfordjournals.eurheartj.a061796DOI Listing

Publication Analysis

Top Keywords

left ventricular
32
ventricular hypertrophy
32
hypertrophic cardiomyopathy
28
patients hypertrophic
20
hypertrophy
12
secondary left
12
ventricular
10
left
9
patients
8
posterior wall
8

Similar Publications

[Clinical characteristics and pharmacological treatment of patients with heart failure in a primary health care cohort].

Aten Primaria

January 2025

Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, España; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès, Barcelona, España; Institut Català de la Salut, Barcelona, España.

Objective: To characterise patients with heart failure (HF) in Primary Health Care (PHC) and describe their socio-demographic and clinical characteristics and pharmacological treatment.

Design: Descriptive cohort study. SITE: Information System for the Development of Research in Primary Care (SIDIAP), which captures information from the electronic health records of PHC of the Catalan Institute of Health (approximately 80% of the Catalan population).

View Article and Find Full Text PDF

Introduction: Haemodynamic atrioventricular delay (AVD) optimisation has primarily focussed on signals that are not easy to acquire from a pacing system itself, such as invasive left ventricular catheterisation or arterial blood pressure (ABP). In this study, standard clinical central venous pressure (CVP) signals are tested as a potential alternative.

Methods: Sixteen patients with a temporary pacemaker after cardiac surgery were studied.

View Article and Find Full Text PDF

This paper proposes the use of artificial intelligence techniques, specifically the nnU-Net convolutional neural network, to improve the identification of left ventricular walls in images of myocardial perfusion scintigraphy, with the objective of improving the diagnosis and treatment of coronary artery disease. The methodology included data collection in a clinical environment, followed by data preparation and analysis using the 3D Slicer Platform for manual segmentation, and subsequently, the application of artificial intelligence models for automated segmentation, focusing on the efficiency of identifying the walls of the left ventricular. A total of 83 clinical routine exams were collected, each exam containing 50 slices, which is 4,150 images.

View Article and Find Full Text PDF

Biomarkers of RV Dysfunction in HFrEF Identified by Direct Tissue Proteomics: Extracellular Proteins Fibromodulin and Fibulin-5.

Circ Heart Fail

January 2025

First Faculty of Medicine, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University (BIOCEV), Charles University, Prague, Czech Republic. (M.B., D.L., O.V., J.P.).

Background: Right ventricular dysfunction (RVD) is common in patients with heart failure with reduced ejection fraction, and it is associated with poor prognosis. However, no biomarker reflecting RVD is available for routine clinical use.

Methods: Proteomic analysis of myocardium from the left ventricle and right ventricle (RV) of patients with heart failure with reduced ejection fraction with (n=10) and without RVD (n=10) who underwent heart transplantation was performed.

View Article and Find Full Text PDF

Objectives: Supra-normal left ventricular ejection fraction (snLVEF) represents a heterogeneous group with distinct prognoses. Left atrial (LA) strain, measured by speckle tracking echocardiography (STE), is a validated prognostic indicator. This study aimed to evaluate LA and left ventricular (LV) mechanical strains in hypertensive patients with snLVEF.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!